SCHEMBL9333284

SCHEMBL9333284

CCc1cc(N)c(=O)[nH]c1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 5/20 0.49
PDE3A Q14432 5/20 0.49
PDE4A P27815 1/20 0.49
PDE4B Q07343 1/20 0.49
PDE4C Q08493 1/20 0.49
PDE4D Q08499 1/20 0.49
AURKB Q96GD4 1/20 0.46
INCENP Q9NQS7 1/20 0.46
GRIN2D O15399 3/20 0.43
GRIN3B O60391 3/20 0.43
GRIN1 Q05586 3/20 0.43
GRIN2A Q12879 3/20 0.43
GRIN2B Q13224 3/20 0.43
GRIN2C Q14957 3/20 0.43
GRIN3A Q8TCU5 3/20 0.43
PARP1 P09874 2/20 0.39
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9432520 0.85 PDE3B (0.44) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL9681961 0.84 PDE3B (0.50) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL9846132 0.76 PDE3B (0.53) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL24551105 0.75 GRIN2D (0.43) PDE3BPDE3AGRIN2DGRIN3BGRIN1
SCHEMBL9456060 0.75 GRIN2D (0.39) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL9846307 0.73 GRIN2D (0.42) PDE3BPDE3AGRIN2DGRIN3BGRIN1
SCHEMBL9431837 0.71 PDE3B (0.49) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL22867594 0.71 DPYD (0.44) PDE3BPDE3AGRIN2DGRIN3BGRIN1
SCHEMBL9274056 0.71 GAA (0.65) PDE3BPDE3AGRIN2DGRIN3BGRIN1
SCHEMBL9265798 0.71 KDM4E (0.53) PDE3BPDE3APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5364776-A Biosynthesis, enzyme inhibitors, treatment of AIDS MERCK & CO., INC. (US) 1994-11-15 US disclosed
US-5308854-A 2-benzoxazolylalkyl substituted pyridin-2(1H)(thi)ones; AIDS MERCK & CO., INC. (US) 1994-05-03 US disclosed
US-5215900-A Biosynthesis a culture product utilizing as enzyme inhibitor in treatment of immune deficiency syndrome MERCK & CO., INC. (US) 1993-06-01 US disclosed
US-5200329-A An Isolating Compound Which is Useful in the Prevention or Tre atment of HIV Infection and the Treatment of AIDS MERCK & CO., INC. (US) 1993-04-06 US disclosed
US-5169769-A Aerobic culture product MERCK & CO., INC. (US) 1992-12-08 US disclosed
CN-1062138-A The synergy of HIV reverse transcriptase inhibitors MERCK & CO INC (US) 1992-06-24 CN disclosed
EP-0484071-A2 Synergism of HIV reverse transcriptase inhibitors MERCK & CO. INC. (US) 1992-05-06 EP disclosed
EP-0481802-A1 Hydroxylated inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1992-04-22 EP disclosed
EP-0462808-A2 Inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1991-12-27 EP disclosed
EP-0462800-A2 Inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1991-12-27 EP disclosed